Results Announcements News Details

Indrayani Biotech Ltd consolidated sales up 107.88% on year in Q1FY2026, net profit soared by 808.33%

(18-Aug-26   12:39)

Indrayani Biotech Ltd share price tumbled by 8.91% to Rs 7.16. The Company's net profit saw a strong growth of 808.33% to Rs 1.09 crore, while revenue from operations gained significantly 107.88% to Rs 72.78 crore in Q1FY26 over Q4FY25. The market capitalization of Other Agricultural Products industry group stocks on BSE stood at Rs 57073.02 crore, gaining 6.64%. It has improved by 0.99% over last one week and gained upto 1.62% in last one month while the market capitalization of Indrayani Biotech Ltd has slipped by 9.25% and 31.03% in the same period respectively. Profit before tax (PBT) of Indrayani Biotech Ltd stood at Rs 0.97 crore in Q1 FY26, crashing by 88.34% year-on-year, and tumbling by 792.86% quarter-on-quarter. EBITDA came in at Rs 3 crore, plunging by 138.62% YoY and surging by 67.86% sequentially. Total expenses witnessed a sharp rise of 110.35% to Rs 69.92 crore in Q1FY26 over Q1FY25. During the quarter, cost of materials consumed stood at Rs 51.38 crore, jumping 96.86% YoY, while employee benefits expense was at Rs 7.49 crore, witnessing a strong rise of 134.06% YoY. For the TTM ended FY26, revenue from operations plunged by 21.66% to Rs 130.23 crore, while net profit witnessed a sharp fall of 158.64% to Rs 6.11 crore, compared to previous TTM. EBITDA surged by 2080% to Rs 3.13 crore, and PBT tanked by 152.32% to Rs 5.74 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 6.74 crore in FY26, as against Rs 30.35 crore in FY25. Indrayani Biotech Ltd crashed 50.24% in last one year, underperforming the benchmark BSE Sensex which has softened by 4.36% during the same period.